𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Growth-inhibitory effects of the synthetic retinoid CD437 against ovarian carcinoma models in vitro and in vivo

✍ Scribed by Simon P. Langdon; Genevieve J. Rabiasz; Alison A. Ritchie; Uwe Reichert; Peter Buchan; William R. Miller; John F. Smyth

Book ID
105994403
Publisher
Springer
Year
1998
Tongue
English
Weight
161 KB
Volume
42
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of the mechanism of induction
Comparison of the mechanism of induction of apoptosis in ovarian carcinoma cells by the conformationally restricted synthetic retinoids CD437 and 4-HPR
✍ William F. Holmes; Dianne Robert Soprano; Kenneth J. Soprano 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 477 KB

## Abstract All‐trans‐retinoic acid (ATRA) has been shown to inhibit the growth of a number of ovarian tumor cell lines while others have been found to be resistant to retinoid suppression of growth. Interestingly, two synthetic retinoids, CD437 and 4‐HPR, inhibit the growth of both ATRA‐sensitive

Contrasting effects of 17 β-estradiol on
Contrasting effects of 17 β-estradiol on the growth of human ovarian carcinoma cells in vitro and in vivo
✍ Simon P. Langdon; Alison Ritchie; Karen Young; A. Jayne Crew; John F. Smyth; Wil 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 708 KB

## Abstract A human ovarian adenocarcinoma cell line (PE04) has been established as a xenograft in nude mice. __In vitro__, this cell line is estrogen receptor (ER)‐positive and its growth is stimulated by 17 β‐estradiol at concentrations between 10^−12^ and 10^−6^ M. When xenografted, PE04 cells r

p-Dodecylaminophenol derived from the sy
p-Dodecylaminophenol derived from the synthetic retinoid, fenretinide: Antitumor efficacy in vitro and in vivo against human prostate cancer and mechanism of action
✍ Noriko Takahashi; Yusuke Watanabe; Yoshie Maitani; Takayasu Yamauchi; Kimio Higa 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 517 KB

## Abstract Fenretinide, __N__‐(4‐hydroxyphenyl)retinamide (4‐HPR) is an aminophenol‐containing synthetic retinoid derivative of all‐__trans__‐retinoic acid, which is a potent chemopreventive and antiproliferative agent against various cancers. Clinical studies of 4‐HPR have shown side effects cons